Neal Walker is CEO & President at Aclaris Therapeutics, Inc. (ACRS). They have made 10 open-market trades across 2 companies since 2014, most recently 2026-02-03.
CIK 0001604457
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $218K since 2014, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRS | SELL | 2023-03-02 | 2023-03-03 | $12.55 | $1.1M | +5.1% | +13.6% | +14.5% |
| ACRS | SELL | 2023-02-01 | 2023-02-03 | $16.69 | $553K | -6.4% | -49.5% | -36.7% |
| ACRS | SELL | 2023-01-03 | 2023-01-04 | $15.14 | $960K | +21.2% | -4.9% | -41.3% |
| ACRS | SELL | 2022-04-21 | 2022-04-25 | $15.15 | $1.1M | -17.6% | -20.2% | +1.5% |
| ACRS | SELL | 2022-03-11 | 2022-03-14 | $15.91 | $1.8M | +23.1% | +9.4% | -9.7% |
| ACRS | SELL | 2022-02-09 | 2022-02-11 | $12.66 | $46K | +11.8% | +14.0% | -19.4% |
| ACRS | SELL | 2021-06-02 | 2021-06-02 | $21.64 | $1.4M | -18.1% | -21.6% | -25.6% |
| ACRS | SELL | 2021-04-22 | 2021-04-26 | $26.84 | $805K | -8.8% | -19.5% | -42.1% |
| ACRS | BUY | 2018-04-05 | 2018-04-09 | $16.75 | $168K | +3.8% | +6.3% | +22.7% |
| ALDX | BUY | 2014-05-07 | 2014-05-08 | $8.00 | $50K | -0.6% | +1.4% | +1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.